Cellular therapy in lymphoma
| dc.contributor.author | Sureda, Anna | |
| dc.contributor.author | Lugtenburg, Pieternella J. | |
| dc.contributor.author | Kersten, Marie Jose | |
| dc.contributor.author | Subklewe, Marion | |
| dc.contributor.author | Spanjaart, Anne | |
| dc.contributor.author | Shah, Nirali N. | |
| dc.contributor.author | Kerbauy, Lucila N. | |
| dc.contributor.author | Roddie, Clarie | |
| dc.contributor.author | Pennings, Elise R.A. | |
| dc.contributor.author | Mahuad, Carolina | |
| dc.contributor.author | Poon, Michelle | |
| dc.contributor.author | Hendricks, Candice Laverne | |
| dc.contributor.author | Kamdar, Manali | |
| dc.contributor.author | Jacobson, Caron | |
| dc.date.accessioned | 2024-08-22T05:41:15Z | |
| dc.date.available | 2024-08-22T05:41:15Z | |
| dc.date.issued | 2024-11 | |
| dc.description | DATA AVAILABILITY STATEMENT : Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. | en_US |
| dc.description.department | Immunology | en_US |
| dc.description.librarian | hj2024 | en_US |
| dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
| dc.description.uri | http://wileyonlinelibrary.com/journal/hon | en_US |
| dc.identifier.citation | Sureda, A., Lugtenburg, P.J., Kersten, M.J., et al. 2024, 'Cellular therapy in lymphoma. Hematological Oncology, vol. 42, no. 6, art. e3200, pp. 1‐9. https://doi.org/10.1002/hon.3200. | en_US |
| dc.identifier.issn | 0278-0232 (print) | |
| dc.identifier.issn | 1099-1069 (online) | |
| dc.identifier.other | 10.1002/hon.3200 | |
| dc.identifier.uri | http://hdl.handle.net/2263/97796 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.rights | © 2023 John Wiley & Sons Ltd. This is the pre-peer reviewed version of the following article : Cellular therapy in lymphoma, Hematological Oncology, vol. 42, no. 6, art. e3200, pp. 1‐9. https://doi.org/10.1002/hon.3200. The definite version is available at : http://wileyonlinelibrary.com/journal/hon. | en_US |
| dc.subject | Chimeric antigen receptor (CAR) | en_US |
| dc.subject | T‐cell therapy | en_US |
| dc.subject | Lymphoma | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.title | Cellular therapy in lymphoma | en_US |
| dc.type | Postprint Article | en_US |
